Newsletter Subject

Threads May Not Replace Twitter in Medicine -- Yet

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Jul 14, 2023 10:52 PM

Email Preheader Text

Daily Headlines Friday, July 14, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT TH

[MEDPAGE TODAY]( Daily Headlines Friday, July 14, 2023 Today's Top Stories for {NAME} [SPECIAL REPORTS]( [Threads May Not Replace Twitter in Medicine -- Yet]( [PSYCHIATRY]( [Injectable Ketamine Shows Promise in Treatment-Resistant Depression]( [NEUROLOGY]( [Why Do Superagers Have Sharper Memory?]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Living with HR+/HER2- Breast Cancer: A Point-of-Care Oral Oncolytic Discussion Guide and Toolkit for Patients]( [CARDIOLOGY]( [Half-Dose TNKase Holds Up for Pharmaco-Invasive Reperfusion in STEMI]( [MEETING COVERAGE]( [FAK Inhibitor Boosts Anti-PD1 Immunotherapy in Pancreatic Cancer]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [T-DXd Effective in Multiple HER2-Expressing Solid Tumors]( CME SPOTLIGHT [Harnessing the Potential of Novel Therapies in Multiple Myeloma]( [MEETING COVERAGE]( [Transcriptional Profiling May Improve Outcomes in Young-Onset Colorectal Cancer]( [ONCOLOGY]( [Adjuvant Nivolumab Promising in Resected Merkel Cell Carcinoma]( [ONCOLOGY/HEMATOLOGY]( [FDA OKs Chinese Drug Imports; Kid Cancers Down But Still Up; J&J Amps Up Talc Fight]( CME SPOTLIGHT [Navigating the Latest Evidence on Multi-Cancer Early Detection Technologies]( [OPINION]( [I Didn't Sign Up for Violence When I Became a Nurse]( [SPECIAL REPORTS]( [After Pushback, J&J Allows Generics of Its TB Drug]( [AAD READING ROOM]( [Spesolimab Remarkably Effective in Treating Generalized Pustular Psoriasis]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Prophylactic and Preemptive Management]( [ACR READING ROOM]( [Guselkumab Resolved 75% of Dactylitis to 1 Year]( [ACR READING ROOM]( [Resolution of Dactylitis With Guselkumab in Patients With Active Psoriatic Arthritis]( [PRACTICE MANAGEMENT]( [CMS Proposes Nearly 3.4% Cut in Medicare Physician Fees for 2024]( CME SPOTLIGHT [Current Evidence and Guidelines for Treatment Selection for Relapsed/Refractory Multiple Myeloma]( [MEDICAL JOURNEYS]( [Case Study: Disease Flare and Fever in Conjunction With Ulcerative Colitis]( [MEDICAL JOURNEYS]( [Case Study: 106-Year-Old Woman Suddenly Develops Rheumatoid Arthritis]( [PRIMARY CARE]( [Aspartame Is a 'Possible' Carcinogen, WHO Declares]( CME SPOTLIGHT [Transforming Patient-Centered Care for HR+/HER2- Breast Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams]( # Weekly Survey [Aspartame: Is It Safe for Patients?]( The WHO [declared aspartame to be a 'possible carcinogen,]( but did not change its recommended daily intake limit for the artificial sweetener.[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-07-14&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.